Regulatory News
Wednesday, April 27, 2016
GSK finds axing doctor payments needn't torpedo sales
LONDON, April 27 (Reuters) - It has been one of the
pharmaceutical industry's most closely watched experiments: does
ending payments to doctors undermine drug sales?
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment